Frontlight ResearchEarly access
Type 2 diabetes trials in Vietnam
4 of 5 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Hanoi, Ho Chi Minh City
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 3Not yet taking people in VietnamA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Hanoi, Hochiminh, Hồ Chí Minh, Hochiminh City, Ho Chi Minh City, Huế, Rach Gia
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - Phase 3Not yet taking people in VietnamA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Haiphong, Hanoi, Hà Nội, Hochiminh City, Ho Chi Minh City, Viet Tri
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00 - No phaseTaking peopleEvaluate the Results of Fall Prevention in Older Adults With Type 2 Diabetes Mellitus
- Where
- Hanoi
- Age
- 60 years to 60 years
- People
- 80
- Run by
- National Geriatric Hospital
See details and how to joinNCT06345118